Published in BMC Neurol on May 26, 2011
Controversies and evolving new mechanisms in subarachnoid hemorrhage. Prog Neurobiol (2013) 1.54
Angiopoietin-1 and Angiopoietin-2 Expression Imbalance Influence in Early Period After Subarachnoid Hemorrhage. Int Neurourol J (2016) 0.75
Effects and mechanisms of docosahexaenoic acid on the generation of angiopoietin-2 by rat brain microvascular endothelial cells under an oxygen- and glucose-deprivation environment. Springerplus (2016) 0.75
Controlling the false discovery rate in behavior genetics research. Behav Brain Res (2001) 21.82
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science (1997) 15.48
Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell (1996) 9.10
Subarachnoid haemorrhage. Lancet (2007) 7.10
Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science (1999) 6.96
Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med (2006) 5.49
Aneurysmal subarachnoid hemorrhage. N Engl J Med (2006) 5.35
Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway. Circ Res (2000) 4.97
The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood (2004) 3.50
Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2004) 3.34
Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol (2006) 3.21
Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry (2007) 3.17
Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria. Proc Natl Acad Sci U S A (2008) 2.80
Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study. Crit Care Med (1995) 2.60
Transcranial Doppler for predicting delayed cerebral ischemia after subarachnoid hemorrhage. Neurosurgery (2009) 2.58
Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators. Crit Care Med (2007) 2.14
Influence of red blood cell transfusion on mortality and long-term functional outcome in 292 patients with spontaneous subarachnoid hemorrhage. Crit Care Med (2009) 2.09
A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke (1991) 1.97
Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients. Crit Care (2008) 1.94
Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children. PLoS One (2009) 1.93
Targets for vascular protection after acute ischemic stroke. Stroke (2004) 1.88
Neurovascular protection reduces early brain injury after subarachnoid hemorrhage. Stroke (2004) 1.79
Circulating angiopoietin 2 correlates with mortality in a surgical population with acute lung injury/adult respiratory distress syndrome. Shock (2008) 1.62
Survival and long-term functional outcome in 1,155 consecutive neurocritical care patients. Crit Care Med (2007) 1.53
Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage. Crit Care (2007) 1.42
Cerebral arterial spasm--a clinical review. Br J Neurosurg (1995) 1.40
Endothelium-derived relaxing and contracting factors. J Cell Biochem (1991) 1.35
Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: putative mechanisms and novel approaches. J Neurosci Res (2009) 1.29
Vasospasm probability index: a combination of transcranial doppler velocities, cerebral blood flow, and clinical risk factors to predict cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg (2007) 1.10
Cellular microparticles as a marker for cerebral vasospasm in spontaneous subarachnoid hemorrhage. Stroke (2010) 1.02
Leaky vessels? Call Ang1! Nat Med (2000) 0.95
Role of p53 and apoptosis in cerebral vasospasm after experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab (2005) 0.94
Mechanisms of disease: roles of nitric oxide and endothelin-1 in delayed cerebral vasospasm produced by aneurysmal subarachnoid hemorrhage. Nat Clin Pract Cardiovasc Med (2004) 0.93
Angiopoietin 1 counteracts vascular endothelial growth factor-induced blood-brain barrier permeability and alleviates ischemic injury in the early stages of transient focal cerebral ischemia in rats. Neurol Res (2009) 0.93
Apoptosis of endothelial cells in vessels affected by cerebral vasospasm. Surg Neurol (2000) 0.87
Regulation of endothelin-1 by angiopoietin-1: implications for inflammation. Exp Biol Med (Maywood) (2006) 0.85
Beyond tie-ing up endothelial adhesion: new insights into the action of angiopoietin-1 in regulation of microvessel permeability. Cardiovasc Res (2009) 0.85
Protective role of COMP-Ang1 in ischemic rat brain. J Neurosci Res (2010) 0.83
High serum levels of growth factors are associated with good outcome in intracerebral hemorrhage. J Cereb Blood Flow Metab (2009) 0.83
Evaluation of angiopoietins and cell-derived microparticles after stem cell transplantation. Biol Blood Marrow Transplant (2008) 0.82
Does low angiopoietin-1 predict adverse outcome in sepsis? Crit Care (2010) 0.81
Hypoperfusion in the acute phase of subarachnoid hemorrhage. Acta Neurochir Suppl (2011) 0.78
Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care (2011) 2.81
The head nodding syndrome--clinical classification and possible causes. Epilepsia (2008) 2.74
European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke (2014) 2.71
Unresponsive wakefulness syndrome: a new name for the vegetative state or apallic syndrome. BMC Med (2010) 2.46
The Bet v 1 fold: an ancient, versatile scaffold for binding of large, hydrophobic ligands. BMC Evol Biol (2008) 2.15
Influence of red blood cell transfusion on mortality and long-term functional outcome in 292 patients with spontaneous subarachnoid hemorrhage. Crit Care Med (2009) 2.09
Safety and efficacy of a novel intravascular cooling device to control body temperature in neurologic intensive care patients: a prospective pilot study. Crit Care Med (2002) 1.82
Serious complications following endovascular thoracic aortic stent-graft repair for type B dissection. Eur J Cardiothorac Surg (2007) 1.81
Risk factors for high-altitude headache in mountaineers. Cephalalgia (2011) 1.64
Frequency of sustained intracranial pressure elevation during treatment of severe intraventricular hemorrhage. Cerebrovasc Dis (2009) 1.63
Traumatic fistula between the middle meningeal artery and the sphenoparietal sinus. Acta Neurochir (Wien) (2009) 1.56
Survival and long-term functional outcome in 1,155 consecutive neurocritical care patients. Crit Care Med (2007) 1.53
Matrix metalloproteinases and their tissue inhibitors (TIMPs) in Plasmodium falciparum malaria: serum levels of TIMP-1 are associated with disease severity. J Infect Dis (2008) 1.51
Computed tomographic parameters predicting fatal outcome in large middle cerebral artery infarction. Cerebrovasc Dis (2003) 1.49
Pretransplantation evaluation of the cirrhotic liver with explantation correlation: accuracy of CT arterioportography and digital subtraction hepatic angiography in revealing hepatocellular carcinoma. AJR Am J Roentgenol (2003) 1.46
Nodding syndrome. Emerg Infect Dis (2013) 1.45
Incidence and treatment of local stenosis or occlusion at the vascular access site leading to limb ischemia and new-onset intermittent claudication after percutaneous interventions: implications of vascular closure devices. Catheter Cardiovasc Interv (2011) 1.38
Pathogenic mutations inactivate parkin by distinct mechanisms. J Neurochem (2005) 1.38
The role of Onchocerca volvulus in the development of epilepsy in a rural area of Tanzania. Parasitology (2010) 1.36
Clinical characteristics of people with head nodding in southern Tanzania. Trop Doct (2010) 1.32
Comparative analysis of protein structure alignments. BMC Struct Biol (2007) 1.28
Epilepsy and neurocysticercosis in rural Tanzania-An imaging study. Epilepsia (2008) 1.26
Language lateralization in temporal lobe epilepsy: a comparison between fMRI and the Wada Test. Epilepsia (2006) 1.18
Prevalence of active epilepsy in a rural area in South Tanzania: a door-to-door survey. Epilepsia (2005) 1.18
Neurological disorders in rural Africa: a systematic approach. Trop Doct (2009) 1.13
Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy. J Neurosurg (2003) 1.13
Prevalence, incidence, and clinical characteristics of epilepsy--a community-based door-to-door study in northern Tanzania. Epilepsia (2009) 1.09
The Lambaréné Organ Dysfunction Score (LODS) is a simple clinical predictor of fatal malaria in African children. J Infect Dis (2009) 1.07
A longitudinal study on nodding syndrome--a new African epilepsy disorder. Epilepsia (2013) 1.05
Attitudes towards African traditional medicine and Christian spiritual healing regarding treatment of epilepsy in a rural community of northern Tanzania. Afr J Tradit Complement Altern Med (2009) 1.04
Effects of the neurological wake-up test on clinical examination, intracranial pressure, brain metabolism and brain tissue oxygenation in severely brain-injured patients. Crit Care (2012) 1.04
Scanning electron microscopy of the neuropathology of murine cerebral malaria. Malar J (2006) 1.04
Cellular microparticles as a marker for cerebral vasospasm in spontaneous subarachnoid hemorrhage. Stroke (2010) 1.02
Consensus summary statement of the International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care : a statement for healthcare professionals from the Neurocritical Care Society and the European Society of Intensive Care Medicine. Intensive Care Med (2014) 1.01
WILMA-automated annotation of protein sequences. Bioinformatics (2004) 1.00
Naturally processed T cell-activating peptides of the major birch pollen allergen. J Allergy Clin Immunol (2010) 1.00
Cerebral perfusion pressure thresholds for brain tissue hypoxia and metabolic crisis after poor-grade subarachnoid hemorrhage. Stroke (2011) 1.00
Type A dissection following endovascular thoracic aortic stent-graft repair. J Endovasc Ther (2005) 1.00
Epilepsy in resource poor countries--suggestion of an adjusted classification. Epilepsia (2007) 0.99
Interleukin-4 promoter polymorphisms: a genetic prognostic factor for survival in metastatic renal cell carcinoma. J Clin Oncol (2007) 0.98
Time course of coagulation parameters, cytokines and adhesion molecules in Plasmodium falciparum malaria. Trop Med Int Health (2004) 0.97
Consensus statement from the 2014 International Microdialysis Forum. Intensive Care Med (2015) 0.96
Belief systems of epilepsy and attitudes toward people living with epilepsy in a rural community of northern Tanzania. Epilepsy Behav (2010) 0.96
Intracranial multimodal monitoring for acute brain injury: a single institution review of current practices. Neurocrit Care (2010) 0.96
Nitration of the pollen allergen bet v 1.0101 enhances the presentation of bet v 1-derived peptides by HLA-DR on human dendritic cells. PLoS One (2012) 0.95
Case report: severe heat stroke with multiple organ dysfunction - a novel intravascular treatment approach. Crit Care (2005) 0.95
Quantitative analysis of hemorrhage volume for predicting delayed cerebral ischemia after subarachnoid hemorrhage. Stroke (2011) 0.95
Accuracy analysis of multiple structure alignments. Protein Sci (2009) 0.95
Mortality patterns and site heterogeneity of severe malaria in African children. PLoS One (2013) 0.94
Anticysticercal and antitoxocaral antibodies in people with epilepsy in rural Tanzania. Trans R Soc Trop Med Hyg (2008) 0.93
Epilepsy and neurocysticercosis in sub-Saharan Africa. Wien Klin Wochenschr (2009) 0.93
Added value of antigen ELISA in the diagnosis of neurocysticercosis in resource poor settings. PLoS Negl Trop Dis (2012) 0.92
Efficacy of silver nanoparticles-impregnated external ventricular drain catheters in patients with acute occlusive hydrocephalus. Neurocrit Care (2008) 0.92
Acute granulomatous acanthamoeba encephalitis in an immunocompetent patient. Neurocrit Care (2010) 0.91
Opposed circulating plasma levels of endothelin-1 and C-type natriuretic peptide in children with Plasmodium falciparum malaria. Malar J (2008) 0.91
Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis. J Antimicrob Chemother (2004) 0.90
Intracortical EEG for the detection of vasospasm in patients with poor-grade subarachnoid hemorrhage. Neurocrit Care (2010) 0.89
Complement factors C1q, C3 and C5 in brain and serum of mice with cerebral malaria. Malar J (2008) 0.89